Research Initiatives Conference

Provided by the
Society for Vascular Surgery®

NADPH Oxidase Inhibition Suppresses Aortic Aneurysm Formation

Jason N MacTaggart, Jason M Johanning, Wanfen Xiong, Iraklis I Pipinos, Rebecca Knispel, B. Timothy Baxter
University of Nebraska Medical Center, Omaha, NE

Objective: Oxidative stress plays a role in abdominal aortic aneurysm (AAA) formation. Nitric oxide in combination with superoxide forms peroxynitrite which is present in both human and animal AAAs. The source of nitric oxide has been investigated but the source of superoxide is unknown. NADPH oxidase and xanthine oxidase are the likely enzymes involved in superoxide production. Our study examined the ability of selective blockade of these two pathways to inhibit aneurysm formation in a mouse model of AAA.
Methods: Beginning 1 week prior to aneurysm induction and continuing to aortic harvest 8 weeks later, groups of C57BL/6 mice were treated with orally administered apocynin (NADPH oxidase inhibitor) or oxypurinol (xanthine oxidase inhibitor). Control mice were given water. AAAs were induced in all animals by periaortic application of calcium chloride. Aortic diameter was measured with video microscopy at aneurysm induction and harvest. The mean diameter and diameter change of each treatment group were compared with concurrent controls using the Mann-Whitney test.
Results: NADPH oxidase inhibition by apocynin blocked aneurysm formation (*P=0.001), while xanthine oxidase inhibition with oxypurinol did not (**P=N.S.).

Pre Post % Increase
Apocynin n=7 540±9µm 574±11µm* 6%±3%
Apocynin concurrent control n=6 529±15µm 813±12µm* 53%±4%
Oxypurinol n=7 527±12µm 712±36µm** 35%±7%
Oxypurinol concurrent control n=7 525±14µm 717±45µm** 37%±9%

Conclusion: Treatment of mice with apocynin, an NADPH oxidase inhibitor, suppresses aneurysm formation in the calcium chloride model of AAA, while treatment with oxypurinol, a xanthine oxidase inhibitor, has no effect. This study suggests that the NADPH oxidase pathway makes an important contribution to the reactive oxygen species involved in AAA development.

Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
© 2010 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.